Additionally, among the 13 patients with NSCLC treated with epidermal growth factor receptor tyrosine kinase inhibitor, Omori et al. report that PD-L1 expression in the tumor tissues increased significantly in five patients (57). This evidence concerns the gene CD274 and non-small cell lung carcinoma.